Healthcare | Ipsos
Healthcare

Centers of Expertise

OUR SOLUTIONS
Global specialist teams that spearhead Ipsos’ expertise and offer in key areas of importance and focus for our clients.

Product Lifecycle CoEs | Therapy Insights CoEs | Market Knowledge CoEs | Innovative Approaches CoEs

Product Lifecycle CoEs

  • Commercial Strategy: Early in the asset development stage, it’s important to understand the key white spaces and opportunities in the market that your new asset could potentially address…
  • Launch Excellence: When preparing for launch, multiple questions arise. How will time and order of entry impact uptake? Who are the key targets? What is the right comms strategy?
  • Performance Optimization: Following the launch of a new product, healthcare companies must monitor product adoption and uptake, and measure the effectiveness of communications and commercialization initiatives…

Let our healthcare product lifecycle experts be your guide in answering these key questions.

Global Contact: [email protected]

Therapy Insights CoEs

  • Oncology: The oncology treatment landscape is evolving at an increasingly rapid pace, creating knowledge gaps with each new fast-tracked approval and change in standard of care…
  • Autoimmune: With an increasing array of new mode-of-action therapies becoming available, autoimmune treatment options continue to expand and pose new paradigms to explore and understand…
  • Virology and Vaccines: The COVID-19 pandemic has reinforced the ever-present threat of viral diseases, and the importance of antivirals and vaccines in managing them…
  • Respiratory: Expanded indications and licenses, plus new biologic therapies and combinations, continue to broaden treatment solutions for patients with common respiratory diseases…
  • Diabetes and Obesity: As the cost of treating diabetes continues to escalate, the spotlight is now on digital and connected health tools to help manage this prevalent condition…
  • Rare Diseases: Healthcare systems are primarily set up to address common diseases, meaning that information gaps often exist around the diagnosis, treatment and patient experience of a rare disease...

Our disease expertise and real-world data can help you navigate these changing dynamics.

Contact: [email protected]

Market Knowledge CoEs

  • Market Access and HEOR: To achieve a strong market access position, it’s critical to effectively navigate the latest challenges, from rapid access in a world of faster drug development to pricing strategies for high-cost curative therapies…
  • Compliance: The pharma and medical device and diagnostics industries are more heavily regulated than ever before – and complete compliance with these standards is business-critical…
  • Multi-Stakeholder Access/Engagement: Identifying, reaching and engaging the right physicians, patients, payers and other stakeholders requires understanding their local market, healthcare system, therapy area, needs and challenges…
  • Medical Devices and Diagnostics (MD&D): The MD&D market is vast, ranging from everyday items to high-risk devices. Each class and type of product presents a unique set of business challenges…
  • Digital and Connected Health: Digital and Connected Health are transforming the way in which healthcare is consumed and delivered. The rise of telehealth, remote patient monitoring and the consumerization of health is fueling the self-care movement…
  • Patients: There is an increasing imperative for the pharma and medical technology industries to shift from a product focus to a patient focus, and adopt more patient-centric business structures and processes.

Let our specialists help you succeed in these business-critical areas.

Global Contact: [email protected]

Innovative Approaches CoEs

  • Data Science and Advanced Analytics: With data lakes created, analytics and data science capabilities built up, and data officers in senior roles, data science is becoming integral to all that our healthcare clients do…
  • Multi-source Data Solutions: An ever-increasing volume of healthcare-related data is available, as are powerful computer algorithms to deal with it – which is why today’s clients expect multi-dimensional research approaches…
  • Innovation: With clients facing new budgetary pressures and new demands on those shrinking budgets, market research must generate even more actionable insights. The answer is innovation…
  • Social Intelligence Analytics: Analyzing and integrating data from multiple real-world sources allows pharma companies to better understand their stakeholders and to become more customer and patient-centric…
  • Qualitative Observation and Activation: To bring human understanding to business decision-making in healthcare, we must bring to life the individuals behind the data and the world in which they live and make decisions…
  • Behavioral Science: Market research has always been informed by psychology, enabling us to identify ways of capturing how people think, feel and behave. While self-reporting is critical, people are not always the most reliable witnesses...

Let our data scientists and methodological experts bring clarity and certainty to your key decisions.

Contact: [email protected]